Amedisys Inc
AMED100.990USD
0.000
Close 11/25, 16:00（ET）Quotes delayed by 15 min
3.32BMarket Cap
36.96P/E TTM
More Details of Amedisys Inc Company
Amedisys, Inc. is a healthcare service company. The Company is engaged in providing care and support in the home. It delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.
Amedisys Inc Info
Ticker SymbolAMED
Company nameAmedisys Inc
IPO dateAug 17, 1994
CEOMr. Richard M. Ashworth
Number of employees19000
Security typeOrdinary Share
Fiscal year-endAug 17
Address3854 American Way, Suite A
CityBATON ROUGE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code70816
Phone12252922031
Websitehttps://www.amedisys.com/
Ticker SymbolAMED
IPO dateAug 17, 1994
CEOMr. Richard M. Ashworth
Company Executives of Amedisys Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Scott G. Ginn
Mr. Scott G. Ginn
Executive Vice President, Chief Financial Officer, Chief Operating Officer
Executive Vice President, Chief Financial Officer, Chief Operating Officer
--
--
Ms. Denise Bohnert
Ms. Denise Bohnert
Chief Compliance Officer
Chief Compliance Officer
--
--
Mr. Nick Muscato
Mr. Nick Muscato
Chief Strategy Officer
Chief Strategy Officer
--
--
Ms. Jennifer Griffin
Ms. Jennifer Griffin
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Scott G. Ginn
Mr. Scott G. Ginn
Executive Vice President, Chief Financial Officer, Chief Operating Officer
Executive Vice President, Chief Financial Officer, Chief Operating Officer
--
--
Ms. Denise Bohnert
Ms. Denise Bohnert
Chief Compliance Officer
Chief Compliance Officer
--
--
Mr. Nick Muscato
Mr. Nick Muscato
Chief Strategy Officer
Chief Strategy Officer
--
--
Ms. Jennifer Griffin
Ms. Jennifer Griffin
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.22%
BlackRock Institutional Trust Company, N.A.
8.05%
Pentwater Capital Management LP
5.22%
Fidelity Investments Canada ULC
3.99%
Alpine Associates Management Inc.
3.34%
Other
70.19%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.22%
BlackRock Institutional Trust Company, N.A.
8.05%
Pentwater Capital Management LP
5.22%
Fidelity Investments Canada ULC
3.99%
Alpine Associates Management Inc.
3.34%
Other
70.19%
Shareholder Types
Shareholders
Proportion
Sovereign Wealth Fund
2.80%
Hedge Fund
1.96%
Individual Investor
1.95%
Investment Advisor/Hedge Fund
0.67%
Investment Advisor
0.33%
Insurance Company
0.04%
Pension Fund
0.02%
Bank and Trust
0.02%
Other
92.21%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
663
31.28M
95.12%
-3.78M
2025Q1
697
31.27M
95.30%
-6.91M
2024Q4
702
30.63M
93.37%
-7.89M
2024Q3
712
30.38M
92.77%
-9.62M
2024Q2
724
31.31M
95.64%
-8.96M
2024Q1
758
31.20M
95.51%
-10.42M
2023Q4
775
32.08M
98.19%
-8.32M
2023Q3
799
30.30M
92.84%
-9.14M
2023Q2
851
31.30M
96.00%
-8.46M
2023Q1
848
33.18M
101.94%
-5.60M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
--
0%
-156.48K
-100.00%
BlackRock Institutional Trust Company, N.A.
--
0%
-37.08K
-100.00%
Pentwater Capital Management LP
--
0%
+370.08K
-100.00%
Fidelity Investments Canada ULC
--
0%
+433.79K
-100.00%
Alpine Associates Management Inc.
--
0%
+104.80K
-100.00%
State Street Global Advisors (US)
--
0%
+60.03K
-100.00%
Norges Bank Investment Management (NBIM)
--
0%
-12.73K
-100.00%
UBS Financial Services, Inc.
--
0%
+244.35K
-100.00%
TIG Advisors, L.L.C.
--
0%
+20.34K
-100.00%
Qube Research & Technologies Ltd
--
0%
+169.44K
-100.00%
View more
Related ETFs
Updated: Wed, Aug 6
Updated: Wed, Aug 6
Name
Proportion
First Trust Merger Arbitrage ETF
7.27%
AltShares Event-Driven ETF
1.97%
SPDR S&P Health Care Services ETF
1.85%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.63%
iShares U.S. Healthcare Providers ETF
0.53%
VictoryShares Small Cap Free Cash Flow ETF
0.48%
ETC 6 Meridian Low Beta Equity Strategy ETF
0.45%
Gotham 1000 Value ETF
0.41%
Global X Aging Population ETF
0.3%
WisdomTree US SmallCap Fund
0.26%
View more
First Trust Merger Arbitrage ETF
Proportion7.27%
AltShares Event-Driven ETF
Proportion1.97%
SPDR S&P Health Care Services ETF
Proportion1.85%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Proportion0.63%
iShares U.S. Healthcare Providers ETF
Proportion0.53%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.48%
ETC 6 Meridian Low Beta Equity Strategy ETF
Proportion0.45%
Gotham 1000 Value ETF
Proportion0.41%
Global X Aging Population ETF
Proportion0.3%
WisdomTree US SmallCap Fund
Proportion0.26%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Amedisys Inc?
The top five shareholders of Amedisys Inc are:
The Vanguard Group, Inc. holds 0.00 shares, accounting for 0.00% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 0.00 shares, accounting for 0.00% of the total shares.
Pentwater Capital Management LP holds 0.00 shares, accounting for 0.00% of the total shares.
Fidelity Investments Canada ULC holds 0.00 shares, accounting for 0.00% of the total shares.
Alpine Associates Management Inc. holds 0.00 shares, accounting for 0.00% of the total shares.
The Vanguard Group, Inc. holds 0.00 shares, accounting for 0.00% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 0.00 shares, accounting for 0.00% of the total shares.
Pentwater Capital Management LP holds 0.00 shares, accounting for 0.00% of the total shares.
Fidelity Investments Canada ULC holds 0.00 shares, accounting for 0.00% of the total shares.
Alpine Associates Management Inc. holds 0.00 shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of Amedisys Inc?
The top three shareholder types of Amedisys Inc are:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Pentwater Capital Management LP
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Pentwater Capital Management LP
How many institutions hold shares of Amedisys Inc (AMED)?
As of 2025Q2, 663 institutions hold shares of Amedisys Inc, with a combined market value of approximately 31.28M, accounting for 95.12% of the total shares. Compared to 2025Q1, institutional shareholding has increased by -0.17%.
What is the biggest source of revenue for Amedisys Inc?
In --, the -- business generated the highest revenue for Amedisys Inc, amounting to -- and accounting for --% of total revenue.
